Targeted Therapies in Cancer: Myth or Reality? /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Colotta, Francesco. (Editor ), Mantovani, Alberto. (Editor )
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Springer, 2008.
Edición:1st ed. 2008.
Colección:Advances in Experimental Medicine and Biology, 610
Materias:
Acceso en línea:https://doi.org/10.1007/978-0-387-73898-7
LEADER 02406nam a22003975i 4500
001 978-0-387-73898-7
005 20191021182203.0
007 cr nn 008mamaa
008 100301s2008 xxu| s |||| 0|eng d
020 |a 9780387738987 
024 7 |a 10.1007/978-0-387-73898-7  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Targeted Therapies in Cancer:  |b Myth or Reality? /  |c edited by Francesco Colotta, Alberto Mantovani. 
250 |a 1st ed. 2008. 
260 # # |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2008. 
300 |a VIII, 191 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Advances in Experimental Medicine and Biology,  |v 610 
505 0 |a Causality in Medicine -- The Evolution of the Biomedical Paradigm in Oncology: Implications for Cancer Therapy -- Anticancer Drug Discovery and Development -- Beyond VEGF: Targeting Tumor Growth and Angiogenesis via Alternative Mechanisms -- Aurora Kinases and Their Inhibitors: More Than One Target and One Drug -- Signalling Pathways and Adhesion Molecules as Targets for Antiangiogenesis Therapy in Tumors -- Developing T-Cell Therapies for Cancer in an Academic Setting -- Anticancer Cell Therapy with TRAIL-Armed CD34+ Progenitor Cells -- Linking Inflammation Reactions to Cancer: Novel Targets for Therapeutic Strategies -- Clinical Development of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors: What Lessons Have We Learned? -- GIST As the Model of Paradigm Shift Towards Targeted Therapy of Solid Tumors: Update and Perspective on Trial Design -- Monoclonal Antibodies in the Treatment of Malignant Lymphomas -- Molecular Network Analysis using Reverse Phase Protein Microarrays for Patient Tailored Therapy. 
650 0 |a Cancer research. 
650 0 |a Human genetics. 
650 0 |a Medicine. 
650 0 |a Human physiology. 
650 0 |a Developmental biology. 
650 1 4 |a Cancer Research. 
650 2 4 |a Human Genetics. 
650 2 4 |a Medicine/Public Health, general. 
650 2 4 |a Human Physiology. 
650 2 4 |a Developmental Biology. 
700 1 |a Colotta, Francesco.  |e editor. 
700 1 |a Mantovani, Alberto.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
856 4 0 |u https://doi.org/10.1007/978-0-387-73898-7